Skip to content

PTHS PTHS Xepi Royalty Agreement — Convertible fees allocated to royalty

Similar metrics at other companies

Innoviva, Inc. logo
INVAXerava — Percentage Of Royalty Payable On Net Sales
0.6%0.0pp
Scilex Holding Company logo
SCLXScilex Pharma — Royalty Expense
$1.2M+33.3%
Boston Scientific logo
BSXRoyalty expense
$12M-14.3%
XOMA Corporation logo
XOMAXaciato — Rights Receivable Cost Recovery Method
$21.99M0.0%
Hercules Capital logo
HTGCRoyalty Contract — Investment cost
$11.5M-3.4%
uniQure logo
QURERoyalty Financing Agreement Interest Expense
$7.17M-14.2%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept pths:ContractualObligationLiabilityConvertibleFeesAllocatedToRoyalty.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's xepi royalty agreement — convertible fees allocated to royalty.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's xepi royalty agreement — convertible fees allocated to royalty?
PTHS (PTHS) reported xepi royalty agreement — convertible fees allocated to royalty of $64K in Q1 2026.
What does xepi royalty agreement — convertible fees allocated to royalty mean?
The portion of convertible fees or upfront costs that have been specifically attributed to the royalty component of the Xepi license agreement. This allocation helps clarify how initial capital outlays are amortized or accounted for against future royalty streams.